SREBF1 and obesity disorder: Another study reported that hepatic mTOR activation in obesity led to the phosphorylation of cytosolic CRTC2 at Ser136, which in turn elicited SREBP1 processing and increased hepatic lipogenesis without any apparent changes in CRTC2 cell localization [33].